WPI 3331 (Bupropion Extended-Release (XL) 150 mg)

Pill imprint WPI 3331 has been identified as Bupropion hydrochloride extended-release (XL) 150 mg.

Bupropion is used in the treatment of major depressive disorder; sexual dysfunction, ssri induced; depression; adhd; anxiety (and more), and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WPI 3331

Bupropion hydrochloride extended-release (XL) 150 mg WPI 3331  Front
Bupropion hydrochloride extended-release (XL) 150 mg WPI 3331  Back
Bupropion hydrochloride extended-release (XL) 150 mg WPI 3331
Bupropion hydrochloride extended-release (XL)
WPI 3331
150 mg
8.00 mm
Prescription only
Drug Class:
Miscellaneous antidepressants
Smoking cessation agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Watson Pharmaceuticals
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide colloidal
hydroxypropyl cellulose
methacrylic acid - ethyl acrylate copolymer (1:1) type a
microcrystalline cellulose
stearic acid
magnesium silicate
titanium dioxide
hydrochloric acid
triethyl citrate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5927 Physicians Total Care Inc (repackager)
21695-0279 Rebel Distributors Corp (repackager)
33261-0449 Aidarex Pharmacuticals LLC (repackager)
53002-1495 Pharmedix (repackager)
33261-0680 Aidarex Pharmacuticals LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.